Dr. Michael Rubin, MD

Dr. Rubin practices at Columbia University Irving Medical Center in New York, New York.

Dr. Rubin's NPI, 1780771873, was assigned on October 9, 2006. Dr. Rubin graduated from McGill University Faculty of Medicine in 1982. Dr. Rubin holds New York license 155335.

Dr. Rubin's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 305-4920.

Dr. Rubin's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Rubin is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Rubin to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rubin practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rubin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rubin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Rubin's licenses on file in 2 states: New York and Florida.

Dmand AI lists carpal tunnel syndrome, cerebrovascular disease, hereditary polyneuropathy, lower back pain, mobility impairment, muscle disease, muscle pain, fibromyalgia, and limb pain and muscle weakness among the conditions Dr. Rubin treats.

CMS data shows 984 Medicare services from Dr. Rubin across 9 procedure codes in 2024, for 484 Medicare patients. Medicare paid $73,659 for them.

CMS counts 484 Medicare patients who saw Dr. Rubin in 2024. The largest group is 75 to 84, with 197 patients. 75% of them have arthritis, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rubin's median patient age at 65, with 53% women.

In 2024, Dr. Rubin wrote 583 Medicare Part D claims for 135 patients. 89% of them were for generic drugs. CMS names the drug for 461 of them, across 12 drugs with 11 or more claims each, at $1,570,831 in total drug cost. In 2023, CMS named 470 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rubin for performance year 2024, reported through an alternative payment model (APM). Dr. Rubin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rubin as offering telehealth.

Dmand AI links 2 papers to Dr. Rubin, published from 2012 to 2022.

CMS Open Payments shows 24 general payments to Dr. Rubin from 1 drug or device company from 2016 to 2025. Consulting fees make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $30,525.

Dmand AI lists 3 awards for Dr. Rubin, most recently CMS Stage 1 EHR in 2013.

Dr. Rubin graduated from McGill University Faculty of Medicine in 1982. Dr. Rubin is a member of AAN.

Dr. Rubin is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.